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Abstract 
 
Purification of Feo Proteins and Analysis of Residues Important for Feo 
Protein Interactions 
Rebecca Rose Morrison, M.A. 
The University of Texas at Austin, 2012 
 
Supervisor:  Shelley M. Payne 
 
Iron is an essential element for virtually all forms of life. Complicating matters, it 
is present in the insoluble ferric form in aerobic environments, while the more soluble 
ferrous form is found in anaerobic or reducing environments. Vibrio cholerae, the 
causative agent of the disease cholera, requires iron to survive. In order to meet the need 
for iron, V. cholerae expresses a variety of iron acquisition systems. One of these 
systems, Feo, is highly conserved among bacterial species as well as archaea and 
transports ferrous iron. The Feo system consists of three proteins: FeoA, FeoB, and FeoC. 
Previous work using the bacterial adenylate cyclase two hybrid system has shown that 
FeoC interacts with the cytoplasmic N-terminal domain of FeoB. However, the 
significance of this interaction is not known. In this study, V. cholerae Feo system 
proteins were analyzed for residues important for the interaction between FeoB and 
FeoC. In addition, FeoA and FeoC were purified for antibody production. It was found 
that a residue in the G protein domain of FeoB was not necessary for interaction with 
FeoC. However, a conserved residue in FeoC did abolish the interaction with FeoB. 
These results indicate that there is at least one residue important in the interaction of 
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FeoB and FeoC, although further characterization will most likely reveal more. 
Antibodies to FeoA and FeoC were generated to use them for further characterization of 
the Feo system.  
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I. INTRODUCTION 
IRON ACQUISITION IN BACTERIA 
Iron is an essential element for nearly all forms of life; however, it can be toxic 
and the levels of intracellular iron require strict control.  Iron can react with oxygen 
species to create destructive oxygen free radicals through the Fenton reaction, causing 
damage to lipids, DNA, and proteins (121).  However, when insufficient iron is present, 
key cellular processes cannot function. Complicating matters further, iron is found in two 
oxidation states with insoluble ferric (Fe
3+
) iron present in oxidative and aerobic 
environments. The more soluble ferrous (Fe
2+
) iron is present in reducing and anaerobic 
conditions.  In order to meet the requirement for iron, bacteria use several strategies to 
regulate iron intake.  
Bacteria must first acquire iron from their surrounding environment, and they 
have numerous systems to accomplish the task of scavenging iron.  Many bacteria secrete 
molecules called siderophores, which are low molecular weight  (500-1000) high-affinity 
iron chelators that bind ferric iron (84). More than 500 siderophores have been described, 
and  the Escherichia coli siderophore, enterobactin, was one of the first siderophores 
discovered and has been well studied(2, 91, 99). Enterobactin consists of three distinct 
parts: the triacetone backbone, the amide linkage, and the metal binding area(103).  In 
Figure 1, the hydroxyl groups shown in red on the metal binding areas interact with the 
iron molecule shown in green through hydrogen bonds. The model on the lower left 
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shows enterobactin without iron and the model on the lower right shows enterobactin in 
complex with iron.  
 
Figure 1. Structure of the E. coli siderophore, Enterobactin.  
Figure from Raymond et al.(103), used with permission. 
  
The siderophore enterobactin binds ferric iron with high affinity, which enables it 
to bind free ferric iron from the environment(103).  Producing siderophores is a common 
strategy to acquire iron used by bacteria; however, secreting molecules into the 
extracellular environment can be costly to the cell. In order to make use of the iron bound 
to siderophores, bacteria use receptors to transport the siderophores bound to iron into the 
cell. Receptors for siderophores bind to the ferri-siderophore with high affinity and help 
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maximize the amount of iron that can be brought into the cell. Ferri-siderophore 
complexes are thought to be too large to pass through the porins that allow small solutes 
to enter through Gram-negative outer membranes and must use a receptor to enter the 
cell(2).  
In Gram-negative bacteria, such as E. coli and V. cholerae, there are two lipid 
membranes and a periplasmic space that the siderophores must traverse. The outer-
membrane consists of an asymmetrical bilayer: the outermost layer consists of lipid-
anchored oligosaccharides and the inner layer consists of phospholipids. Next is the 
aqueous periplasmic space that contains many enzymes, chaperone proteins, and 
transport factors as well as a thin layer of peptidoglycan, which confers rigidity to the cell 
and maintains the cell shape(100). Lastly, the cytoplasmic membrane is composed of a 
phospholipid bilayer that is rich in proteins that harvest ion gradients for energy 
conversion(100).  
The outer-membrane receptors for siderophores have high affinity for their 
ligands, which enables efficient uptake of the molecule. The enterobactin receptor in E. 
coli, FepA, as well as other receptors has been crystallized. All of these proteins are β-
barrels that cross the outer membrane and have an N-terminal globular domain that can 
open the channel in response to siderophore binding (11).  Figure 2 below illustrates the 
catechol- type siderophore-mediated ferric iron transport system of E. coli. 
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Figure 2. E. coli K-12 siderophore-mediated ferric iron transport.  
The outer membrane receptors for catechol-type siderophores are FepA, Cir, and Fiu. The 
periplasmic binding protein is FepB. The cytoplasmic permease consists of FepD and 
FepG. The ABC proteins are composed of FepC. Note that TonB-ExbB-ExbD interacts 
with all of the outer membrane receptors, not just Fiu. Adapted from Andrews et al. (2), 
used with permission. 
 
Bacteria often have receptors for both the siderophore they produce as well as for 
siderophores produced by other bacterial species.  For example, Vibrio cholerae produces 
the siderophore vibriobactin, but it also produces  receptors for enterobactin and 
ferrichrome (40).  By having receptors for several different siderophores, the bacteria can 
take advantage of siderophores produced by other bacteria in the environment, lowering 
the energy expenditure needed to acquire iron. 
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Binding of the ferri-siderophore to the receptor induces conformational changes 
believed to prime the interactions with the TonB system(2).   TonB, ExbB, and ExbD use 
energy generated from the  proton motive force of the cytoplasmic membrane to power 
the transport of siderophores through their receptors (56, 100). TonB spans the 
periplasmic space, and is stabilized in the cytoplasmic membrane by ExbB and ExbD as 
noted in figure 2 (52, 109). Receptors that interact with TonB have a conserved sequence, 
called the TonB box, where TonB physically interacts with the receptor and provides the 
energy needed to drive transport (2).  
The interaction of TonB with an outer-membrane receptor allows the siderophore 
to be transported into the periplasmic space. Transporting the siderophore across the 
periplasm and the cytoplasmic membrane involves a periplasmic binding protein and an 
associated cytoplasmic permease. These proteins follow a general configuration: the 
periplasmic binding protein ferries the siderophore to the appropriate cytoplasmic 
permease, while the permeases in the cytoplasmic membrane have an ATP- binding 
cassette to power transport across the cytoplasmic membrane. It is not clear whether the 
periplasmic binding protein directly interacts with the outer-membrane receptor or if it is 
merely close to the receptor(64).  The best characterized of the siderophore periplasmic 
binding proteins is FhuD from E. coli, and it interacts with iron hydroxymate 
siderophores(25). As with most other periplasmic binding proteins that shuttle iron 
ligands, it is a bilobal protein. The protein or proteins that allow the siderophore through 
the inner membrane may be composed of a homodimer, a heterodimer, or one large unit. 
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In the figure above, FepB is the periplasmic binding protein, while FepD and FepG 
compose the cytoplasmic permease(85). The ABC unit is generally made of two ATPase 
proteins, which may be identical.  In the figure above, FepC is an ATPase that powers 
transport of the siderophore across the cytoplasmic membrane and is associated with 
FepD and FepG(66). As outlined in figure 2, Cir and Fiu are also outer-membrane 
receptors that transport Fe
3+
-dihydroxybenzoic acid and Fe
3+
-dihydroxybenzoyl serine 
respectively(2). Nikaido et al.(86) proposed that these receptors may help E. coli recover 
the hydrolytic products of enterobactin from the environment(86).  Siderophores brought 
in through Cir and Fiu are transported by FepBCDG into the cytoplasm(2). 
Pathogenic bacteria take advantage of host iron sources, although the host iron is 
sequestered in an effort to limit the bacterial infection (12).  Mammals lower iron levels 
to about 10
-18
 M in tissue fluids, which cannot support bacterial growth(12). The host 
proteins, transferrin and lactoferrin, are used by the host to solubilize and transport iron in 
normal conditions. Lactoferrin is also an antimicrobial protein produced by host cells to 
bind iron in extracellular compartments and can limit growth of organisms including E. 
coli and P. aeruginosa (4, 83). However, some pathogenic organisms such as Neisseria 
meningitidis are able to retrieve the iron from lactoferrin (95). Receptors for transferrin as 
well as lactoferrin have been identified in Neisseria and other organisms (102). These 
receptors strip the iron from lactoferrin or transferrin and release the surrounding protein 
to the external environment. They also utilize the TonB system and Fbp to ferry the iron 
to the cytoplasm(1).  
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As heme and hemoglobin are some of the most abundant sources of iron in the 
human body, it is not surprising that bacteria have evolved methods to obtain this store of 
iron. Access to host heme stores can be accomplished by hemophores secreted into the 
extracellular environment where they scavenge heme from assorted hemoproteins due to 
the hemophores higher affinity for heme, and return heme to their particular outer-
membrane receptor(21).  However, some bacteria bind heme directly at their surface(35). 
The heme molecule is bound and transported through an outer membrane receptor using 
the TonB system and an ABC type cytoplasmic membrane transporter.  
FEO- A MAJOR FERROUS IRON TRANSPORT SYSTEM 
Bacteria can also transport ferrous iron in addition to ferric iron. Ferrous iron 
(Fe
2+
) is the more soluble oxidative state of iron, but it is only present in low oxygen and 
reducing environments.  This makes is it likely that ferrous iron is the predominant form 
of iron in areas such as the human intestine. A conserved operon called feo (ferrous iron 
transport) is present in approximately fifty percent of bacterial genomes that have been 
sequenced and transports ferrous iron(45). It is present in organisms as diverse as 
cyanobacteria(22), archea(53), gram-negative bacteria(53) and gram-positive 
bacteria(57).   The Feo system was discovered in 1987 in E. coli in a screen for mutants 
deficient in ferrous iron transport(44).  The feo operon consists of feoA, feoB, and feoC.  
FeoB is thought to be the ferrous iron permease, while the functions of FeoA and FeoC 
are uncertain.  FeoA and FeoC are both small, hydrophilic proteins of approximately 
8kDa. E. coli FeoB is 773 amino acids in length and contains several integral membrane 
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domains(124) . The configuration of this operon and the encoded proteins is illustrated 
below. 
 
 
 
 
Figure 3. FeoABC operon and protein localization.  
Adapted from Cartron et al.(20),used with permission. 
 
In bacterial species that contain the feo operon, 80% have feoA immediately 
upstream of  feoB(20).  FeoA has weak homology with the SH3-like domain of DtxR of 
C. diptheriae, which suggests that FeoA might participate in facilitating interactions with 
other proteins (20). A structural study of FeoA has confirmed it contains an SH3-like 
domain, consistent with the hypothesis that it is involved in interactions with other 
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proteins(116). In addition, a feoA mutation prevented the uptake of Fe
2+
 through the Feo 
system, suggesting that FeoA is necessary for ferrous iron acquisition(63). Recently, 
FeoA was shown to interact with FeoB in Salmonella enterica using the bacterial 
adenylate cyclase two-hybrid system (BACTH) (63). The BACTH system is based on the 
Bordetella pertussis secreted adenylate cyclase (59). This molecule has two catalytic 
domains, which do not function when separated. However, if each catalytic domain is 
fused to an interacting protein then the adenylate cyclase activity will be restored (60). 
This process allows for screening for interactions between proteins. If two proteins 
interact, then the bacteria will turn blue when grown on plates containing the indicator X-
gal and display increased activity in a beta-galactosidase assay. Thus, with the evidence 
from the BACTH and other studies, the prevailing hypothesis is that FeoA interacts with 
FeoB.  
FeoB is a large, membrane spanning protein with an N-terminal G protein 
domain. G proteins normally function in cellular signaling and in regulation of diverse 
cellular processes. The G protein domains interact with guanine nucleotides as GTPases 
that hydrolyse GTP to GDP, with GTP “turning on” processes and GDP turning them off. 
In vitro, the G protein domain  cycles through a nucleotide-free state, or “apo” form;  
however, a GTP molecule quickly binds to the nucleotide-free G protein domain(17). The 
loss of the GDP nucleotide from the G protein is a crucial part of regulating G proteins: 
the loss of GDP allows the cycling of the G protein from GDP to the apo form and back 
to the GTP-bound state. The amount of time that the G protein is bound to GDP 
correlates to the amount of time that the G protein is in the “off” configuration.   
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Critical elements that regulate whether GTP or GDP is bound to the G protein 
domain or if it is in the apo state include guanine-nucleotide exchange factors (GEFs) and 
GTPase activating proteins (GAPs). The GAP proteins increase the rate of GTP 
hydrolysis, while GEFs as increase the rate of GDP removal(8).  The G protein domains 
consist of 5 G regions that contact the guanine-nucleotide as well as a magnesium ion. 
The binding of the GTP molecule causes a conformational change in two regions known 
as switch I and switch II which allows effector proteins to interact and initiate 
signaling(42).   
 
 
Figure 4. Crystal structure of FeoB and GTP. 
 Figure from Guilfoyle et al.
 
(42)
 
, used with permission. 
 
Sequence analysis of the integral membrane domain of FeoB has predicted that it 
has between eight and twelve transmembrane domains, depending on the species and the 
prediction program used(20).  Crystal structures of on the cytoplasmic N terminus of 
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FeoB have provided more insight into the workings of FeoB. A crystal structure of the 
portion of FeoB containing the G protein domain and the linker domain with GDP  and a 
water molecule shows how FeoB positions the water molecule to initiate GTP 
hydrolysis(6).  There are several other structures of the G protein domain of FeoB, which 
all show that FeoB has considerable homology to other G proteins. Crystal structures 
have been determined for  the N terminus of FeoB in Streptococcus thermophilus(5), E. 
coli (42), Thermotoga maritima(47), Klebsiella pneumoniae(53), Pyrococcus 
furiosus(53), Methanococcus jannaschii(65), and Legionella pneumophila (94). 
However, the interpretation of some of the results are conflicting, as studies have claimed 
that FeoB is a monomer(47), dimer(94), and a trimer (42).   
Other studies have revealed more consistent results. In vitro studies show that the 
G protein domain of cytoplasmic portion of FeoB has a slow rate of GTP hydrolysis and 
a fast release of GDP, which would suggest that the G protein is usually  in the “on” 
position(70). The Unger group(31) has demonstrated that the linker domain between the 
N-terminal G protein domain and the membrane-spanning loops might act as a guanine-
nucleotide dissociation inhibitor; therefore, it could act as a regulator on an otherwise 
unusual G protein domain causing FeoB to remain in the GDP-bound state longer (31). 
The Jormakka(5) group established that the GTPase activity of FeoB is  potassium 
activated, since potassium leads to a 20 fold increase in the GTP hydrolysis rate of 
FeoB(5). These in vitro results suggest that although FeoB has a slow rate of GTP 
hydrolysis and a fast release of GDP on its own, it is most likely regulated so that it is not 
in the “on” position for as long. 
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Genetic investigation has revealed insights into the feo operon and confirmed its 
role in ferrous iron acquisition. The G protein domain of FeoB is necessary for ferrous 
iron uptake through Feo, which was determined by random insertional mutagenesis (68). 
The switch regions of FeoB were important for transport of ferrous iron through Feo as 
shown by E. coli mutants which were able to bind and hydrolyze GTP but were non-
functional in vivo (31).   
FeoC is less conserved than either FeoA or FeoB and has been associated with γ-
proteobacteria(20). Like FeoA, it is a small, hydrophilic protein, but it has been proposed 
from sequence analysis to have a winged-helix structure within its N-terminus. This 
structure normally binds DNA, leading to the speculation that FeoC is a transcriptional 
regulator of the feoABC operon(10, 20). Guo et al.(43) showed that a feoC deletion in Y. 
pestis increased resistance to cationic antibiotics. They suggest that as FeoC has been 
reported to be a repressor of feoAB, then the increase in resistance to cationic antibiotics 
would be due to derepression of feoAB. Once feoAB has been derepressed, then the 
amount of ferrous iron in the cell would increase. Indirectly, the increase of ferrous iron 
could turn on genes needed for resistance to cationic antibiotics. However, a deletion of 
feoC in Y. pestis done by the Perry group had no effect on Feo function(93). Recent 
evidence has also shown that it binds the G protein domain of FeoB in K. 
pnuemoniae(54). The role of FeoC remains unclear and further work is needed to 
elucidate its function.   
The feo operon has a different genetic organization in some organisms. 
Interestingly, there are cases where multiple feoA genes are associated a single feoB in an 
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operon. In these cases, the two FeoA homologs are evolutionary distant by sequence 
analysis (20). The evolutionary distance may suggest that each FeoA protein has 
developed functional specialization. Remarkably, there are also two FeoB sequences in 
some species. When multiple feoB genes are present, they shown signs of genetic 
divergence based on sequence analysis. This may signify that the evolutionary pressure is 
likely lessened on the duplicated gene, which then can more freely evolve a new function. 
As this operon is present in such diverse species, it is logical that the organization may 
have diverged in some of them.  
The Feo system and ferrous iron acquisition have also been implicated in disease. 
It is probable that the reducing, low oxygen environment inside the host intestine makes 
ferrous iron the more abundant form; therefore, ferrous iron acquisition is an important 
process for bacterial life inside the intestine. In S. flexneri, the feoABC operon was 
induced in anaerobic conditions, by the anaerobic regulators ArcA and Fnr as shown in 
vitro (9). In Salmonella species, the two-component response regulator, PhoP/Q, turns on 
feoB transcription in response to acidic pH(24). This may help Salmonella sense when it 
is entering a host as the bacteria must pass through the human stomach, which is highly 
acidic. This further supports that Feo is important under oxygen-limiting conditions such 
as those seen inside a host. Specifically, Feo has been linked to virulence with 
Streptococcus suis(3), S. typhimurium(123), Yersinia pestis(32), Helicobacter 
pylori(124), Legionella pneumophilia(104), Campylobacter jejuni(82), and is even 
associated with virulence in plant pathogens such as Xanthomonas oryzae(92). The fact 
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that this conserved operon is also responsible for virulence in many different host 
systems makes further study and characterization important.  
OTHER FERROUS IRON ACQUISITION SYSTEMS  
Other means of transporting ferrous iron include the metal ABC type transporters.  
These include SitABCD from S. typhimurium and YfeABCD from Y. pestis. The Sit 
system was discovered within a pathogenicity island in S. typhimurium and is required for 
murine infection(131). However, further research has shown that although Sit does 
transport ferrous iron, its major function may be in Mn
2+
 transport in S. typhimurium 
(131).  In Shigella flexneri, Sit has a minor role in ferrous iron acquisition when inside a 
host epithelial cell, but a mutant in sitA showed reduced growth in vitro (106).  Sit may 
also be important for S. flexneri to survive in macrophages, as a sitA mutant was 
defective in surviving exposure to hydrogen peroxide, one of the bacteriocidal 
mechanisms of macrophages(107). Unlike S. typhimurium, S. flexneri Sit is more 
involved in iron transport than manganese (33). The Yfe system of Y. pestis is required 
for murine infection, and a mutant that had two genes in the yfeABCD operon deleted 
showed reduced growth in the presence of an iron chelator(93).   
Another ferrous iron acquisition system is the EfeUOB system. The genes are 
arranged in a three gene operon which is expressed during iron starvation. EfeU shows 
homology to the high-affinity yeast iron permease, Ftr1p, suggesting that it acts as the 
permease in the EfeUOB system(18).  The functions of EfeO and EfeB are unclear, 
although a crystal structure of EfeO suggests that is involved with metal binding(101). 
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The efeUOB operon is repressed at high pH and is de-repressed at low pH as evidenced 
by the examination of transcriptional fusions(18). 
The EfeUOB system was discovered in the E. coli Nissle 1917 strain(41). In 
many laboratory strains such as E. coli K12, the first gene in the operon (EfeU) has a 
frame-shift mutation that abolishes this system’s function(41). This frame-shift mutation 
prevented the discovery of the efeUOB operon until 2006 (41). However, pathogenic 
strains of E. coli such as O157:H7 display a functional system(18).    
Other ferrous iron acquisition systems may be involved in the transport of other 
metal ions, but can be used during times of iron starvation to maximize the amount of 
iron brought in to the cell. One of these systems is the ZupT system of E. coli. It was 
initially described as a metal permease responsible for the uptake of zinc but has since 
been shown to display a broad substrate specificity for divalent metal cations(38, 39). 
ZupT transports zinc and ferrous iron as well as cobalt, manganese, and cadmium.  zupT 
expression does not seem to be induced or repressed by any metals but is instead 
transcribed at a low constitutive level(120).   
E. coli mntH encodes a protein believed to be membrane associated and is similar 
to the eukaryotic NRAMP family, which transports divalent metal cations(69). MntH was 
found to have a higher affinity for manganese and ferrous iron in transport studies, but 
can transport many divalent cations as evidenced by competition assays(69). In S. 
typhimurium, MntH was found to be more important in manganese transport, and mntH 
expression is regulated by hydrogen peroxide as well as ferrous iron or manganese when 
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present(62). It has been implicated in virulence in the mouse as well as H2O2 
resistance(62).  
BACTERIAL IRON REGULATION  
Iron is important for almost all forms of life and yet can be toxic in large 
quantities. Therefore, the regulation of iron transport is just as imperative as its 
acquisition in order for the cell to survive. The master regulator of iron acquisition in 
many bacteria is Fur (ferric uptake regulator). Fur was first found in E. coli in a screen 
investigating the regulation of ferric iron uptake systems, and the Δfur mutant showed 
constitutive expression of iron transport genes such as fhuA and fepA(46). Fur is a 17kDa 
protein and acts as a homodimer that represses transcription of iron acquisition systems in 
iron-replete conditions (26). In high iron conditions, one ferrous iron molecule binds per 
subunit of the dimer, changing the Fur dimer’s confirmation and allowing it to bind to 
conserved Fur boxes in the DNA preventing transcription(26). Structural studies have 
also shown Fur to bind zinc at a distinct site, most likely for structural purposes(98).  
 
 
  17 
 
Figure 5. Crystal Structure of P. aeruginosa Fur dimer  
Figure from Pohl et al. (98) The DNA binding domains are shown in blue and the 
dimerization domains in green. In red are the zinc ions.  
 
 The majority of genes repressed by Fur involve iron acquisition; however, genes 
not associated with direct iron acquisition system function are also repressed by Fur.  
yqiH, the gene in E. coli responsible for reducing siderophore-bound ferric iron coming 
from siderophores, is regulated by both Fur and a divergently transcribed gene, yqjI(80, 
125). The product of this gene may not be directly involved in acquiring iron, but it does 
have a role in iron usage in the cell. In S. typhimurium, Fur was required for the activity 
of sodA, which is a superoxide dismutase that contains Mn
2+ 
and is responsible for 
protecting the cell from superoxide damage(122). The regulation of sodA by Fur may 
result in turning on mechanisms to protect the cell in times of high intracellular iron 
levels, when damage is most likely to occur.   Fur also plays a role in virulence in 
pathogens, as the shiga-like toxin of E. coli is negatively repressed by Fur(16).  
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Figure 6. Action of Fur on target gene transcription  
There are also some genes induced in the presence of Ferri-Fur. It was later found 
that this induction does not happen as a result of Fur, but is rather provided by another 
layer of iron regulation mediated by the small RNA, RyhB. This sRNA is responsible for 
some genes being indirectly induced by Fur because Fur represses ryhB, which encodes a 
post-transcriptional negative regulator of genes whose products use iron. RyhB 
accomplishes the negative regulation of these transcripts by binding to its target mRNA 
in an anti-sense fashion along with the chaperone, Hfq. Both RyhB and the target mRNA 
are degraded by RNaseE. RyhB controls around 20 mRNAs (~60 proteins) whose 
products are non-essential and bind iron (73). Thus, when the intracellular iron level is 
high, iron acquisition genes are turned off and genes whose products use iron are turned 
on, including sodB and fumA in E. coli(72).  Therefore, RyhB restricts iron usage only to 
essential proteins during times of limited iron availability. The presence of both Fur and 
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RyhB allow the bacterium to fine-tune the iron usage and acquisition, maximizing the 
efficiency of the cell. 
VIBRIO CHOLERAE 
Virtually all forms of life require iron. One particular organism that has many 
systems to acquire iron and is implicated in human disease is V. cholerae. The diversity 
of its iron acquisition systems and its role in human disease makes it an interesting and 
important organism to study. V. cholerae, the causative agent of cholera, is a gram-
negative rod that has been implicated in global pandemics and caused many fatal 
infections. According to the World Health Organization, there are an estimated three to 
five million cases of cholera a year resulting in 100,000 to 120,000 deaths(90). This 
organism lives in several different environments, including both marine habitats and in 
the human gastrointestinal tract. In the marine environment, V. cholerae may associate 
with copepods and other marine organisms(55, 118). 
 It is introduced to humans by drinking contaminated water. In studies using 
human volunteers, about 10
11
 organisms were required to cause disease(58), but that 
number is lowered to between 10
3
 and 10
4
 when the organisms were delivered with an 
antacid to decrease the acidity of the stomach(58). Once ingested and passed through the 
stomach, V. cholerae colonizes the small intestine using its toxin co-regulated pilus, 
TcpA(51). Once the organism has adhered to an intestinal epithelial cell through the 
toxin-coregulated pilus, then cholera toxin binds to a receptor on the epithelial cell 
surface, GM1, and following a cascade of events causes disregulation of the second 
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messenger cAMP(58). This causes the epithelial cell to pump out chloride ions releasing 
vast amounts of water and electrolytes which cause the rice water stools characteristic of 
cholera(58).  
The symptoms of cholera in its milder form are generally the same as 
gastroenteritis including vomiting and abdominal discomfort, but can become life-
threatening in the severe form, cholera gravis(58). Even if no symptoms are perceived by 
the host, bacteria are spread through the stool, potentially infecting many more people by 
contaminating water supplies. Merrell et al.(74) proposed that passage of the bacteria 
through the intestine of the host results in a hyper-infectious state that is maintained once 
outside the host, which may contribute to epidemic spread(74). Symptoms of cholera 
usually begin within 5 days and are accompanied by sudden diarrhea. The volume of 
stool is large in cholera patients and especially with the more severe form of the disease. 
Dehydration is the most clinically relevant effect of cholera and most treatment consists 
of oral or intravenous rehydration. In cholera gravis, hypotension and cardiac arrest can 
occur because of the profound loss of fluid and electrolytes. 
V. cholerae possesses many virulence factors, including the toxin coregulated 
pilus and cholera toxin.  Many of the factors are regulated by ToxR, a trans-membrane 
protein responsible for binding to the promoter of at least 17 genes. These genes include, 
ctxA, the cholera toxin gene and for the gene encoding a transcriptional activator, ToxT, 
causing a cascade of virulence factors to be produced(29). Later studies have confirmed 
the role of ToxR and ToxT but they have also shown that there are other regulators that 
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increase expression of virulence factors encoded by tcpPH(7). These virulence factors 
may respond in part to oxygen levels, as anaerobiosis increased proteins involved in 
biofilm formation and virulence factors(71).   
Different biotypes of V. cholerae can account for the severity of the disease to 
some degree. Pandemic forms of V. cholerae are split into two major serogroups: O1 and 
O139, which are responsible for most epidemics, while other serogroups only 
occasionally result in outnbreaks(110).  O1 can be further broken down into two 
biotypes: classical and El Tor, and into two major serotypes, Inaba and Ogawa(34). 
Classical biotypes are more often associated with cholera gravis than the El Tor 
biotypes(58, 96).  However, new strains are developing in Asia and Africa which seem to 
cause a much more severe disease and are associated with higher fatality rates. These 
new strains have a mix of classical and El Tor characteristics, resulting in a more virulent 
organism(89). Furthermore, there is evidence that strains normally endemic in certain 
regions of the world are evolving and mixing characteristics from Inaba and Ogawa 
serogroups(23, 34). 
There is also evidence that cholera is seasonal, with increases in bacteria 
corresponding to algal bloom in marine and estuary habitats(58). This seasonality may in 
fact reflect higher temperatures and higher nutrient availability in the marine environment 
rather than the presence of algae species. There is also evidence that cholera has occurred 
in waves of pandemics throughout modern history with the 7
th
 pandemic occurring right 
now(81).  
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The most recent epidemic has been hard on the poverty-stricken nation of Haiti. 
In 2011, Haiti had more than 250,000 cases and 4,000 deaths within the first six months 
of the epidemic, making it one of the most deadly in recent history(30). It is thought that 
V. cholerae had such a large impact in Haiti due to the presence of a population naïve to 
the organism, the lack of clean drinking water, and unsanitary conditions (30, 97). The 
outbreak in Haiti brings to light the need of proper sanitation and access to clean drinking 
water to prevent V. cholerae from infecting humans.   
VIBRIO CHOLERAE SPECIFIC IRON ACQUISITION  
V. cholerae is an excellent model organism for iron acquisition due to the ease of 
study and the importance of understanding the basic science of V. cholerae to better 
design treatments and preventative measures. Since iron is required for its life, studying 
iron acquisition and the conserved Feo operon could provide vital information in fighting 
the organism and the disease it causes. As a result of the many iron acquisition systems, 
V. cholerae is able to live in many different environments.  
 V. cholerae has many genes that code for several different iron acquisition 
systems. V. cholerae makes the siderophore vibriobactin(40) but contains receptors for 
both vibriobactin(13) and two for enterobactin(77). It is thought that V. cholerae would 
not encounter E. coli in the human to make use of enterobactin, but enterobactin may be 
more important for growth in the environment(127).  Vibriobactin consists of a 
norspemidine backbone and three dihydroxybenzoate moieties attached to the 
backbone(40). The pathway for converting dihydroxybenzoate (DHB) from chorismate is 
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identical as that for enterobactin and involves VibABC(130).  Vibriobactin assembly 
involves DHB, threonine, and norspermidine and requires VibBDEFH(14, 61).  
 
Figure 7. Structure of Vibriobactin  
Figure from Griffiths et al(40), used with permission.  
 
The gene encoding the vibriobactin receptor is viuA. Downstream of viuA is viuB 
which is most likely functioning in the removal of iron from the ferri-siderophore as it 
suppressed a fes mutation in E. coli (13). fes is a gene in E. coli that is known to encode a 
protein that removes iron from the ferri-siderophore. The genes for the receptors for 
enterobactin transport are irgA and vctA. IrgA and VctA show sequence similarity to 
CirA of E. coli(37) and FetA of Neisseria gonorrhoeae(19), respectively.  In addition to 
enterobactin, V. cholerae is able to use agrobactin(40) and a siderophore made by Vibrio 
fluvialis(127), which is expected to be fluvibactin(112). V. cholerae is most likely able to 
transport these siderophores because their structure is similar to vibriobactin and are able 
to use the vibriobactin receptor(127). In addition, V. cholerae can use ferrichrome as a 
source of iron(40). The genes involved in this are fhuABCD(105).   
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V. cholerae has two periplasmic-binding protein dependent ABC transport 
systems for the transport of catechol siderophores called ViuPDCG and VctPDGC (128). 
Mutants with defects in either system are still able to transport both siderophores 
indicating that there is some flexibility in their binding capacity and they are not limited 
to either enterobactin or vibriobactin(79).  
V. cholerae also uses heme and hemoglobin as iron sources(114). There are three 
genes for receptors for heme in V. cholerae which are hutA, hutR, and hasR(75). Less is 
known about the usage of heme once it has been transported into the cell. It was found 
that the gene hutZ was required for efficient heme usage(50, 75, 129). hutZ is found in 
the hutWXZ operon, which is divergently transcribed from the TonB1 system genes.  
Functions have not been assigned for hutWX. A crystal structure of HutZ showed a 
similarity to the HugZ protein of H. pylori, which is a heme oxygenase. The authors of 
this study, Liu et al.(67), noted that HutZ was closely related to HugZ, but no heme 
oxygenase activity could be described for HutZ in that study. They proposed that a 
divergence in one of the conserved regions of both proteins could account for the 
structural and functional mismatch. However, a recent study by Uchida et al.(117), found 
that HutZ bound to heme in the presence of ascorbate may act as a heme oxygenase to 
degrade heme(117). Further study of HutZ will elucidate the function of the hutWXZ 
operon and its relationship with heme.  
Interestingly, V. cholerae contains two TonB-ExbB-ExbD systems. One of these 
operons, designated tonB1, is cotranscribed with hutBCD, which encodes an inner 
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membrane heme transport system. The second operon, tonB2, has low homology to 
tonB1 operon but is able to restore function in a tonB mutant in E. coli when introduced 
on a plasmid(88). Further characterization has shown that the two TonB systems have 
over-lapping as well as specific functions(109). For example, transport though HasR  is 
TonB2 dependent but transport using either HutA or HutR was TonB1 dependent(75) .  
V. cholerae also has TonB-independent transporters. fbpABC, which encodes a 
periplasmic binding protein, a cytoplasmic permease, and an ATPase(126). The FbpABC 
proteins show a 50% sequence similarity to the FbpABC proteins of Mannheimia 
haemolytica, which is the most closely related species for which functional information is 
obtainable(108). To test whether the V. cholerae Fbp system is functional for iron 
transport, it was cloned on a plasmid and transformed into a Shigella flexneri mutant, 
SM193w, which is severely defective for iron transport and cannot grow without the 
addition of either an added functional iron transport system or exogenous siderophore. 
The addition of fbpABC on a plasmid to SM193w supported the growth of this strain, 
indicating that it encodes a functional iron transport system. The transport of 
55
Fe 
SM193w with fbpABC was inhibited in the presence of the reducing agent ascorbate, 
indicating that this system is involved in the transport of ferric iron (126). 
V. cholerae also has the Feo system for ferrous iron acquisition. This system 
consists of all three feo genes: feoABC. feoA and feoB are 40%  identical to the E. coli 
homologs, but FeoC contains only 11% identity to the E. coli version. This may suggest a 
different function for FeoC in V. cholerae (126).  To test whether feoABC encoded a 
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functional iron transport system, it was transformed into SM193w. Supplying either the 
E. coli feo operon or the V. cholerae feo operon allowed SM193w to grow without 
supplemental siderophore, which suggests that they are functional iron transport 
systems(126).    
In previous work done by Emily Helton in her doctoral dissertation(49), it was 
shown that all three proteins, FeoA, B, and C, are needed for ferrous iron transport using 
the Feo system(49).  Helton showed, using the bacterial adenylate cyclase two hybrid 
system (BACTH), that FeoB and FeoC interact. The interaction between FeoB and FeoC 
was greatest using the first 272 amino acids of FeoB, which includes the G protein 
domain and the linker domain, with the full length FeoC. A mutation in FeoC changing 
glutamate 29 to glycine abolished that interaction. This glutamate is conserved between 
Vibrio species, but is not conserved in E. coli. This residue may be important for either 
FeoC’s function or structure. Further study of important residues in both FeoB and FeoC 
may help elucidate the function of FeoC.  
Helton also found that the feoABC operon is induced under anaerobic and acidic 
conditions. These conditions closely match those seen in the human host; supporting the 
idea that ferrous iron and the Feo system may be important for V. cholerae survival in the 
human(49). 
In addition to iron acquisition genes, V. cholerae also has the global iron 
acquisition regulator, Fur.  Fur acts much the same way in V. cholerae as it does in other 
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bacteria: it represses iron acquisition genes in iron-replete conditions.  V. cholerae Fur 
regulates almost all iron acquisition genes as well as other genes involved in 
pathogenicity, such as those encoding the toxin-coregulated pilus(78). The effect on the 
toxin coregulated pilus was confirmed because the V. cholerae fur mutant weakly auto-
agglutinates. Supporting the link between Fur and virulence is the fact that the fur mutant 
was not able to compete with the wild-type strain for mouse colonization(78).  V. 
cholerae Fur was crystallized which revealed some differences to Fur in E. coli(111). 
There are two zinc binding sites, but the second zinc binding site (Zn2) is thought to be a 
regulatory iron binding site and the first zinc binding site (Zn1) is thought to play a 
secondary role and not participate in DNA binding. There is also no evidence for metal 
binding to cysteine residues as there is in E. coli(111). However, all five potential metal 
binding domains remained conserved between V. cholerae and P. aeruginosa Fur, 
indicating that these residues are important for Fur function(111).  
V. cholerae also possesses the sRNA RyhB involved in iron regulation. V. 
cholerae RyhB is regulated similarly to E. coli RyhB as it is repressed by ferri-Fur, but V. 
cholerae RyhB is much longer than the E. coli RyhB (200 vs. 90 nucleotides in length) 
and it regulates an additional subset of genes in V. cholerae, including genes involved in 
motility, chemotaxis, and biofilm formation (28, 76). As all of these processes are needed 
for the bacteria to infect a host, these data further reinforce the role of iron in 
pathogenesis.  
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PURPOSE OF THIS RESEARCH 
Although the functions of the Feo proteins have become clearer in recent years, 
the roles that they play have not been fully determined. Even the basics of Feo activity 
are not completely understood. The goal of this study is to provide better understanding 
of the function of all three genes, and that the functions of FeoA and FeoC will become 
clearer as they are the least understood. As ferrous iron acquisition has been shown to be 
an important part of life inside the human host, it may be noted that understanding this 
system could lead to a better understanding of pathogen iron acquisition inside the host 
and have far reaching effects on treatment of bacterial pathogens.  
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II. MATERIALS AND METHODS 
BACTERIAL STRAINS AND PLASMIDS 
Bacterial strains used in this study are listed in Table 1.  Bacterial plasmids used 
in this study are listed in Table 2.  E. coli DH5α was used for routine cloning procedures.  
E. coli BTH101 was used in the bacterial two-hybrid assays. E. coli BL21 (DE3) was 
used for protein expression.  
MEDIA, REAGENTS AND GROWTH CONDITIONS 
E. coli strains were grown in Luria-Bertini (LB) broth (1% tryptone, 0.5% yeast 
extract, 1% sodium chloride) or on LB agar.  Unless otherwise indicated, antibiotics were 
used at the following concentrations per milliliter: 25 µg ampicillin, 30 µg 
chloramphenicol, and 50 µg kanamycin. E. coli BTH101 was routinely grown at 30°C.  
To induce expression of two-hybrid constructs, isopropyl β-D-1-thiogalactopyranoside 
(IPTG) was used at a final concentration of 0.5 mM or as indicated.  When used, bromo-
chloro-indolyl-galactopyranoside (X-gal) was added to LB agar at a concentration of 40 
µg/mL. 
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Table 1 Bacterial Strains Used in This Study 
 
Strain     Relevant Characteristics   Source 
DH5α    endA1 hsdR17 supE44 thi-1 recA1 
 gyrA relA1 (lacZYA-argF)  
U169 deoR [80dlac(lacZ)M15] 
BTH101   F
-
, cya-99, araD139, galE15, galK16, Euromedex 
 rpsL1 (Str
r
), hsdR2, mcrA1, mcrB1 
BL21 (DE3) fhuA2[lon],ompT,gal,(λDE3)[dcm]∆hsdS New England  
λ DE3 = λ sBamHIo ∆EcoRI-B  Biolabs 
     int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5 
 PLASMID DNA ISOLATION, RESTRICTION DIGESTION AND LIGATIONS 
Plasmid DNA was isolated using GenElute Plasmid Miniprep Kit (Sigma) and 
eluted into either10 mM Tris, 1 mM EDTA buffer or MilliQ water and stored at -20˚C.  
Restriction digestion was performed according to New England Biolab’s protocols. 
Following manufacturer’s protocol, DNA was isolated from agarose gels using GenElute 
Gel Extraction Kit (Sigma).  Ligation of DNA was performed using T4 DNA ligase (New 
England Biolabs).  DNA molecular weight markers were purchased from New England 
Biolabs and included ΦX174 DNA-Hae III digest and lambda DNA-HindIII digest. All 
procedures using the commercial reagents were done according to the manufacturer’s 
protocol. 
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Table 2 Plasmids Used in this Study 
 
Plasmid  Relevant Characteristics Source 
 pKT25   Low-copy-number vector encoding T25 under 
control of lac promoter, MCS at 3’end of T25 
Euromedex 
pKNT25 Low-copy-number vector encoding T25 under 
control of lac promoter, MCS at 5’end of T25 
Euromedex 
pUT18 High-copy-number vector encoding T18 under 
control of lac promoter, MCS at 5’ end of T18 
Euromedex 
pUT18C High-copy-number vector encoding T18 under 
control of lac promoter, MCS at 3’ end of T18 
Euromedex 
pKT25-zip pKT25 carrying leucine zipper of GCN4 Euromedex 
pUT18C-zip  pUT18C carrying leucine zipper of GCN4  Euromedex 
pKT25FeoB  pKT25 carrying V. cholerae feoB   E. Helton 
pKT25FeoB272 pKT25 carrying V. cholerae feoB, encoding 
amino acids 1-272  
E. Helton 
pKT25FeoB272- D72A pKT25 carrying V. cholerae feoB, encoding 
amino acids 1-272 with the D72A mutation 
This study 
pUT18CFeoC  pUT18C carrying V. cholerae feoC E. Helton 
pUT18CFeoC-E29G  pUT18C carrying V. cholerae feoC with E29G 
mutation  
E. Helton 
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TRANSFORMATION 
Cells were made competent by diluting overnight cultures 1:100 into LB 
broth(250 µL overnight culture into 25 mL LB broth) plus appropriate antibiotics and 
growing to mid-log (OD650=0.5-0.8).  Cells were centrifuged at 7000 rpm (Rotor - 
Sorvall SS-34) for 7 minutes and the pellets were resuspended in 10 mL of cold 100mM 
CaCl2.  Cultures were incubated on ice for 30 minutes.  Cells were centrifuged at 7000 
rpm for 7 minutes at 4°C and resuspended in 2 mL cold CaCl2 solution (100 mM CaCl2, 
15% glycerol).  Cells were divided into 150 µL aliquots and stored at -80°C.  Heat-shock 
transformation was accomplished by adding DNA to CaCl2-competent cells and 
incubating on ice for 1 hour.  The cells were then heat-shocked at 42°C for 1 minute and 
incubated on ice for 2 minutes.  The cells were then added to 1 mL LB broth and 
incubated at 37°C for 1 hour prior to plating on LB agar plus appropriate antibiotics.   
Table 2 continued 
  
pUT18CFeoC-M35A pUT18C carrying V. cholerae feoC with M35A 
mutation  
This study 
pET16b T7 Expression vector including an N-terminal 
His•Tag  and three cloning sites.  
Novagen 
pET16bFeoA  pET16b carrying V. cholerae feoA  This study 
pFeo128 pET25b carrying V. cholerae feoC E. Wyckoff 
pFeo101 pWKS30 carrying V. cholerae feoABC E. Wyckoff 
VcFeoD72A pFeo101 carrying V. cholerae feoB with D72A 
mutation  
M. Walters 
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POLYMERASE CHAIN REACTION 
Oligonucletide primers used in this study are listed in Table 3. Primer design was 
completed using MacVector (MacVector, Inc, Cary, NC).  Primers were obtained from 
Sigma.  Primers arrived lyophilized and were resuspended in double distilled water to a 
concentration of 100 µM and stored at -20°C.  All PCR reactions used in plasmid 
construction were performed using KOD Hot Start (Novagen) according to the 
manufacturer’s protocol.  PCR reactions used to confirm plasmids were performed using 
Taq polymerase (New England BioLabs), according to the manufacturer’s protocol.  
DNA sequencing was performed by the DNA Sequencing Facility at the University of 
Texas Institute for Cellular and Molecular Biology on ABI 3730XL and ABI 3730 DNA 
sequencers. 
 
Table 3. Oligonucleotide primers used in this study 
Primer Name    Nucleotide Sequence (5’ to 3’) 
pUT18C.497  CGGGCAACTGAAGGAATACACATTG 
pUT18C.950Rev GATGACGGTGAAAACCTCTGACAC 
FeoA.Nde  GTTCATATGAAATTGTCACAAATGCAA 
FeoA.Bam.rev  GCGGATCCTCATTGTGCTCTCTCCAC 
Feo227B  ACTCTAGAGATGAAGTATCAACTACTCAC 
Feo238  ATACCCGGGCTTTTTCGGTGAATTTATGG 
FeoC.M35A.for GAAGATGGCATCGATGCGGCGCTCGCGGTATGGATTAA 
FeoC.M35A.rev TTAATCCATACCGCGAGCGCCGCATCGATGCCATCTTC 
For2   TGTAAAACGACGGCCAGT 
Rev2   GGAAACAGCTATGACCATG 
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CONSTRUCTION OF PLASMIDS 
1. pKT25FeoB272-D72A: The mutated form of FeoB was amplified from Vcfeo 
D72A plasmid acquired from Michelle Walters using the primer pair Feo227B and 
Feo238. The PCR product was then cut with SmaI and XbaI and ligated into pWKS30. 
The FeoB272-D72A fragment was removed from pWKS30 using SmaI and XbaI and 
ligated into pKT25, that had been digested with SmaI and XbaI.  
 
2. pUT18CFeoC–M35A: The pUT18CFeoC plasmid was amplified using 
FeoC.M35A.for and FeoC.M35A.rev to introduce the M35A mutation according to the 
QuikChange manufacturer’s protocol(115). The PCR product was then digested with 
DpnI to degrade the template.  
 
3. pET16bFeoA: FeoA was amplified from pFeo101 using the primers FeoA.Nde and 
FeoA.Bam.rev. The PCR product was ligated into pBluescript, which had been digested 
using SmaI.  pBluescript and FeoA and were digested using NdeI and BamHI. FeoA was 
ligated into pET16b, digested with NdeI and BamHI.  pET16b contains a deca-His tag on 
the N terminal end along with a T7 promoter.  
Β-GALACTOSIDASE ASSAYS 
A single colony from a plate was used to inoculate a culture of LB broth 
containing IPTG, ampicillin, and kanamycin.  After 24 hours of growth at 30°C with 
aeration, β-galactosidase assays were performed as described by Miller (74).   
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PURIFICATION OF FEO A AND FEOC 
To purify FeoC, BL21 (DE3) carrying pFeo128 was grown overnight at 30°C in 
LB plus ampicillin and then sub-cultured 1:100 into 100 mL of LB plus ampicillin. The 
cells were grown at 30°C to an OD650 of 0.5. IPTG was then added to a final 
concentration of 0.5 mM and growth continued for 1 to 2 hours. Initial experiments 
indicated that His-tagged FeoC was insoluble in cultures grown under these conditions, 
so it was purified from the pellet fraction. The culture was then centrifuged (Rotor- 
Sorvall SS-34 for 10 minutes at 10,000 rpm), and the pellet was resuspended in 4 mLs of 
20 mM Tris-HCl pH 8.0. The cells were disrupted using sonication, centrifuged, and the 
pellet was resuspended in 3 mLs of isolation buffer (2M urea, 20 mM Tris-HCl pH 8.0, 
0.5 M NaCl, and 2% Triton X-100). The pellet containing FeoC was sonicated, 
centrifuged, and resuspended in isolation buffer a total of three times. The final pellet was 
resuspended in 5 mLs of binding buffer (6M guanidine HCl, 20 mM Tris-HCl pH 8.0, 0.5 
M NaCl, and 20 mM Imidazole).  This was stirred for one hour at room temperature and 
centrifuged for 15 minutes at 15,000 rpm at 4°C. The supernatant was filtered through a 
0.45 µm syringe filter (Acrodisc by Pallo) and loaded onto an AKTA FPLC (GE 
Healthcare Life Sciences). A 1 mL HisTrap HP nickel column (GE Healthcare) was used. 
A gradient from 0 to 100% refolding buffer (20 mM Tris-HCl pH 8.0, 0.5M NaCl and 20 
mM imidazole) was added over 20 mL to refold FeoC while on the column. The column 
was washed with 5 mL refolding buffer and then FeoC was eluted in a 5 mL gradient 
from 0 to 100% elution buffer (20 mM Tris-HCl pH 8.0, 0.5 M NaCl, and 0.5M 
imidazole). FPLC fractions were stored at -20° C. Protein concentration from FPLC 
fractions likely to contain FeoA or FeoC was determined according to the protocol 
developed by Bradford.   
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BL21 (DE3) cells carrying pET16bFeoA were used to produce FeoA. The same 
protocol was used to purify FeoA except for the following changes: 200 mL of culture 
was induced with IPTG at a concentration of 1 mM. 
 A SDS 15% polyacrylamide gel was loaded with either FeoA or FeoC  with 5 µL 
of purified protein and 10 µL of SDS-PAGE sample buffer to assess the purity of the 
fraction. After, electrophoresis, the gel was stained with Coomassie Blue.  
ANTIBODY PRODUCTION 
Purified FeoA (~1.2 mg) and FeoC (~1 mg) were sent to Cocalico Biologicals Inc. 
for antibody production. Two rabbits were immunized with a total of 5 injections (FeoA) 
or 6 injections (FeoC). The rabbits were exsanguinated after the final immunization.  
WESTERNS FOR EVALUATING FEOA AND FEOC ANTIBODY ACTIVITY  
To evaluate the antibody activity of FeoA and FeoC, samples were prepared from 
cells were grown in the following manner. DH5α cells containing either pET25b or 
pFeo101 were grown overnight at 30°C and sub-cultured 1:100 into 5 mL LB and 
antibiotics. The cells were grown to OD650= 0.6. 1 mL of cells was centrifuged and the 
pellet was resuspended in 200 µl of SDS-PAGE sample buffer. BL21 (DE3) cells 
containing either pET25b or pET16bFeoA were grown overnight at 30°C and then 
diluted 1:100 into fresh media and grown until the OD650 reached 0.5-0.8. The cells were 
then induced with IPTG at a final concentration of 1mM for three hours.  Equal numbers 
of cells (OD650=1) were centrifuged and the pellet was resuspended in 200 µL of SDS-
PAGE sample buffer.  Samples were boiled for 3 minutes and loaded onto a SDS- 15% 
polyacrylamide gel.  Samples of purified FeoC were prepared by mixing 5 µL of fraction 
C1 was mixed with 10 µL of SDS-PAGE sample buffer.  After electrophoresis, one gel 
was stained with Coomassie Blue stain and proteins from an identically loaded gel were 
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transferred to a 0.45 µM nitrocellulose membrane.  After blocking the membrane 
overnight in 5% powdered milk in Tris-buffered saline (TBS)-Tween (10 mM Tris pH 
8.0, 150 mM NaCl, 0.05% Tween-20), the membrane was blotted with various dilutions 
of the appropriate serum.  The membrane was then washed three times for 5 minutes in 
TBS-Tween and incubated with a goat anti-rabbit IgG HRP-labeled secondary antibody 
(Bio-Rad) at a 1:10,000 dilution in 5% milk (in TBS-Tween).  The signal was detected by 
developing the blot using the Pierce ECL-detection kit (Thermo Fisher Scientific, Inc). 
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III. RESULTS AND DISCUSSION 
A RESIDUE IN THE SWITCH REGION OF FEOB IS NOT NEEDED FOR INTERACTION WITH 
FEOC 
G protein domains have long been known to regulate the function of diverse 
cellular processes in eukaryotes(36). G proteins have more recently been found to be 
present in prokaryotes where they also serve a regulatory function(15, 27, 119).  In vitro 
studies have shown that FeoB has homology to known G proteins in eukaryotes and 
prokaryotes and that FeoB is a G protein(70). Studies by Marlovitz et al.(70) on the N 
terminal portion of FeoB showed that this protein hydrolyzed GTP as a GTPase (70). 
However, GTP hydrolysis by purified FeoB was slowed compared to other G proteins as 
discussed in the introduction(70). As the rate of GTP hydrolysis of FeoB is slow, it is 
probable that a protein may modulate FeoB to increase the rate of hydrolysis or to 
facilitate the binding of GDP. A potential candidate to modulate FeoB is FeoC, as it is 
part of the Feo system and has been shown to interact with FeoB. 
The switch regions of G proteins are responsible for changing the conformation of 
the G protein when GTP is bound, allowing the G protein domain to interact with 
downstream effectors(113). To investigate the function of the switch region, Eng et 
al.(31) generated mutations in the switch region of the G protein, and the GTP binding 
affinity and hydrolysis rates of the mutant proteins were measured. FeoB containing a 
D73A mutation in switch II bound and hydrolyzed GTP with near wild-type affinity, but 
was non-functional for iron transport in vivo(31). These data suggest that GTP binding 
and hydrolysis by the G protein domain is not sufficient for  FeoB activity(31). 
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The corresponding mutation was made in V. cholerae to test whether a mutation 
in the switch region of the G protein domain affected FeoB function in this organism. In a 
previous experiment, the V.  cholerae FeoB D72A mutation prevented Feo-mediated iron 
acquisition in SM193w.  Also a previous experiment showed that FeoC interacts with the 
G protein domain of FeoB(49, 54).  To see if the FeoB D72A mutation interrupted the 
interaction with FeoC, the mutated FeoB and wild-type FeoC were tested for interaction 
using the bacterial adenylate cyclase two hybrid (BACTH) system in order to gain more 
insight into the function of FeoC.  
The BACTH system is based on the secreted adenylate cyclase of B. pertussis, as 
described previously. This process allows for screening for interactions between proteins. 
If two proteins interact, then the bacteria will turn blue on media containing X-gal and 
display increased activity in a beta-galactosidase assay.  When grown on media 
containing X-gal, the bacteria containing the first 272 amino acids of FeoB (FeoB272) 
and FeoC interact and display adenylate cyclase activity as evidenced by the blue color of 
the colonies, indicating the presence of β-galactosidase. Bacteria containing various 
combinations of either the vector alone or the vector with either FeoB272 or FeoC did not 
show adenylate cyclase activity and the colonies were white. 
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Figure 8. A mutation in the switch region of FeoB does not interrupt the interaction of 
FeoB and FeoC.  
The FeoB switch region mutation D72A was introduced into FeoB fused to the T25 
fragment of the BACTH system plasmid and tested for its ability to interact with FeoC 
fused to the T18 fragment. BTH101 was transformed with both plasmids and grown to 
OD650=1. β-galactosidase activity was measured (Miller Units) as an indication of 
interaction between fused proteins. Wild-type FeoB272 fused to T25 and FeoC fused to 
T18 were included as a positive control, and empty vectors were the negative control. 
This figure represents the results of a single experiment. 
As revealed by the bacterial two hybrid system in figure 8, the mutation in the 
switch region of V. cholerae FeoB did not affect the interaction with FeoC in this system 
in this single experiment. This might mean that FeoC does not modulate the activity of 
FeoB, as the switch regions are responsible for changing the arrangement of the G protein 
domain in response to GTP binding and are good candidates for modulation. However, 
FeoC may interact in this region primarily with different amino acids, it may interact in 
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another region of FeoB, or may act to regulate the function of FeoB in a different manner. 
Further work is needed to better understand the FeoB switch region’s role in the Feo 
system. 
A CONSERVED RESIDUE IN FEOC ABOLISHED THE INTERACTION WITH FEOB 
FeoC is the least conserved protein between V. cholerae and E. coli, showing only 
11% identity. An examination of the amino acid sequence of V. cholerae FeoC compared 
to the sequence from E .coli revealed a small region of conservation. This region 
represents most of the conserved residues between V. cholerae and E. coli in FeoC and in 
the middle of this conserved region is a methionine. The role of this conserved region in 
interaction was tested, and methionine 35 was focused on as it was in the center of the 
conserved region. 
 
V. cholerae FeoC -MILNELKAAIESKNGATRQELARRFALSEDGIDAMLAVW 
E. coli FeoC     MASLIQVRDLLALRGRMEAAQISQTLNTPQPMINAMLQQL 
                     
 
V. cholerae FeoC IKKGVLSRQQYINAEDEVVRVRYVMNQVGSLAVNVTM--- 76 
E. coli FeoC     ESMGKAVRIQ--EEPDGCLSGSCKSCPEGKACLREWWALR 78 
                   
Figure 9. Alignment of FeoC from V. cholerae and E. coli.  
Blue highlighted regions indicate conserved residues. The pink highlighted residue 
indicates methionine 35. The alignment was generated using ClustalW (European 
Bioinformatics Institute).  
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A point mutation was made changing the methionine at position 35 to an alanine 
residue and the point mutant was tested using the bacterial two hybrid system described 
above. Bacteria containing FeoB272 and FeoC with the M35A mutation were white and 
did not show adenylate cyclase activity as shown in figure 10. 
 
 
 
 
 
 
 
 
Figure 10.A mutation in FeoC abolishes the interaction with FeoB. 
 A mutation in the conserved region of FeoC, M35A, was introduced to FeoC fused to the 
T18 fragment of the BACTH system plasmid and tested for its ability to interact with 
FeoB272 fused to the T25 fragment. BTH101 was transformed with both plasmids and 
grown overnight on LB containing X-gal. β-galactosidase activity was measured by the 
blue colony appearance as indication of interaction between the fused proteins. In each 
area, the BTH101 cells contained the indicated plasmids at the bottom of the figure.  
1 – pKT25FeoB272 pUT18CFeoC         4 – pKT25 pUT18CFeoC 
2 – pKT25 pUT18C                                5 – pKT25 pUT18CFeoCM35A 
3 – pKT25FeoB272 pUT18C                 6 – pKT25FeoB272 pUT18CFeoCM35A                      
1 
2 
3 
4 
5 
6 
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The white colony appearance and the loss of adenylate cyclase activity indicates 
that there was no measurable interaction between FeoB and FeoC when FeoC contained 
the M35A mutation.  The loss of interaction suggests that the methionine in the 35
th
 
position is important for the interaction between FeoC and FeoB272. Bacteria containing 
FeoCM35A and FeoB272 were also tested using a beta-galactosidase assay to verify the 
results seen on the media containing X-gal. This assay confirmed that FeoCM35A no 
longer interacted with FeoB 272 as the Miller units were similar to those of the plasmids 
without any insert. 
 
 
 
 
 
 
 
 
Figure 11. A mutation in FeoC abolishes the interaction between FeoB and FeoC. 
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 A mutation in a conserved region of FeoC , M35A, was introduced into FeoC fused to 
the T18 fragment of the BACTH system plasmid and tested for its ability to interact with 
FeoB272 fused to the T25 fragment. BTH101 was transformed with both plasmids and 
grown to OD650=1. β-galactosidase activity was measured (Miller Units) as an indication 
of interaction between fused proteins. Wild-type FeoB272 fused to T25 and FeoC fused 
to T18 were included as a positive control, and empty vectors were the negative control. 
This assay was done in triplicate. Error bars indicate one standard deviation. 
One possible explanation for the white colonies on X-gal plates and the lowered 
β-galactosidase activity is that this conserved methionine 35 is important for FeoC 
contacting FeoB. There is evidence from Klebsiella species that FeoC binds to FeoB as 
evidenced by a crystal structure with FeoC bound to FeoB; however, the function of this 
binding has not been discovered(54). Another explanation for the loss of interaction 
between FeoB272 and FeoCM35A is that methionine 35 is important structurally. It is 
possible that when changed from methionine to alanine, the protein is misfolded and is 
degraded.  Further work is being performed to examine whether FeoCM35A levels are 
comparable to wild-type FeoC levels.  
ANTIBODY PRODUCTION FOR FEOA AND FEOC 
Antibodies for the Feo system proteins in V. cholerae would be useful in assays 
that could provide a more detailed picture of the interaction between these proteins. To 
commence antibody production, feoA was cloned into the expression vector pET16b 
which contains an N-terminal His-tag, the bacteriophage T7 expression system, including 
the promoter, transcription start site, and the terminator of T7, for high levels of 
transcription and translation, as well as the lac operator region. Using pET16b allows for 
most of the bacterial cell’s resources to be devoted to the expression of the target gene, 
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with the some expressed proteins encompassing more than 50% of the cell’s total protein 
hours after induction using this system(87).    
 
 
  
 
 
 
Figure 12. Plasmid map of pET16b with landmarks noted 
The level of induction can be controlled by the concentration of IPTG used, as the 
host strain, BL21 (DE3), has the T7 RNA polymerase under the control of lac promoter. 
As IPTG is a molecular mimic of allolactose and binds to the lac repressor, it is able to 
induce the transcription of the T7 RNA Polymerase. The cells were induced using IPTG, 
and it was determined that FeoA was in the insoluble fraction of the cellular lysate. It is 
most likely that overexpressing FeoA caused it to misfold and aggregate into inclusion 
bodies. 
This suggested that denaturation and on-column refolding of FeoA would be the 
best course of action. The cells were sonicated, filtered, solubilized in a denaturing 
solution as described in the methods section(48). The protocol used high concentrations 
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5711 bp 
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of urea and guanidine hydrochloride to denature and solubilize FeoA. Denatured FeoA 
was passed through a nickel column using an FPLC to separate the His-tagged FeoA 
protein from the other cellular proteins. Following the binding of the denatured FeoA 
onto the column, on column refolding was accomplished by decreasing the concentration 
of urea and guanidine hydrochloride. Finally, the refolded FeoA protein was eluted using 
a Tris buffer containing a high concentration of imidazole, which efficiently competes for 
binding to nickel and causes the His-tagged FeoA to elute from the column. In Figure 13, 
the second lane contains DH5α cells with the pET16b vector alone as a negative control 
that should not show a significant band in the area expected for FeoA. The third lane 
contains DH5α cells expressing pFeo128 as a positive control that should show a FeoA 
band. Lanes 4 and 5 contain fractions from the FPLC purification and they both contain 
FeoC at observable levels.  
 
 
 
 
 
Figure 13. Coomassie-stained SDS-PAGE gel of FPLC purification of FeoA. 
10 
15 
Lane 1 Molecular Weight Marker 
Lane 2 pET16b 
Lane 3 pFeo128 
Lane 4 B12 
Lane 5 C1 
   1      2      3      4       5 
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 Arrow indicates expected FeoA position. In lane 1 is the molecular weight marker 
Presicion plus protein dual color standard (Bio-rad). The 10 kDa and 15 kDa positions 
are labeled. In lane 2 is DH5α containing the empty pET16b vector as a negative control. 
In lane 3 is DH5α containing the pFeo128 as a positive control. In lanes 4 and 5 are the 
FPLC fractions B12 and C1 containing purified FeoA.  
The fractions likely to contain the protein based on UV absorption spectra 
generated by FPLC system (see Fig. 13) were analyzed and protein concentration was 
estimated using the Bradford assay. The amount of FeoA from two fractions was 
approximately 1.2 mg (Fig. 13 lanes 4 and 5). This was then sent to Cocalico Biologicals, 
Inc. for antibody production using two rabbits.  A total of 5 immunizations against FeoA 
were performed in each rabbit.  
 
 
 
 
 
Figure 14. Pre-immune serum activity for FeoA.  
Arrow indicates expected FeoA position. Serum from rabbits UT641 and UT642. In lane 
1 is DH5α containing pFeo101. In lane 2 is DH5α containing pET16b. In lane 3 is BL21 
(DE3) containing pET25b. In lane 4 is BL21 (DE3) containing pET16bFeoA.  
  The pre-immune serum from one of the rabbits (UT641) showed a high level of 
reactivity to E. coli proteins. The western blot of the serum activity of UT641 in Figure 
1: DH5α pFeo101 whole cell 
2: DH5α pET16b whole cell 
3: BL21 (DE3) pET25b whole cell 
4: BL21 (DE3) pET16bFeoA 
1   2    3    4 1    2    3    4 
UT641 UT642 
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14 indicates that further purification will be needed to use that serum to isolate the 
antibodies specific for V. cholerae FeoA. The pre-immune serum from UT642 showed no 
activity however. In figure 13, the lanes containing the purified FeoA show only the band 
for FeoA, but the western blot of the pre-immune serum from rabbit UT641 shows 
multiple bands in each lane. The band of interest is indicated by the arrow in the figure, 
although all lanes show a band at this size. This indicates that this rabbit most likely 
encountered E. coli previously. It is of note that FeoA and FeoC bands are visualized as 
the same size. The serum from rabbit UT642 showed little background and had high 
specificity for the recombinant FeoA. The western blot in Figure 15 shows that the 
antibody from UT642 binds to FeoA isolated from BL21 DE3 cells containing 
pET16bFeoA with high affinity.  Figure 15 also shows that the serum did not react to the 
cells containing only the vector as evidenced by the lack of band in lane 3. However, the 
serum did not react with pFeo101 which is puzzling, but this may be a result of poor 
expression in DH5α. Serum from rabbit UT641 showed multiple bands in each lane. 
 
 
 
 
 
Figure 15. Antibody Activity against FeoA.  
1: DH5α pFeo101  
2: DH5α pET16b  
3: BL21 (DE3) pET25b  
4: BL21 (DE3) pET16bFeoA  
1    2   3    4     1    2    3    4     
UT641 UT642 Coomassie 
1     2     3    4     
15 
10 
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Arrow indicates expected position of FeoA. Serum is from rabbits UT641 and UT642 
diluted 1:200 in 5% powdered milk and TBS-Tween. In lane 1 is DH5α containing 
pFeo101 as a positive control. In lane 2 is DH5α containing pET16b alone as a negative 
control. In lane 3 is BL21 (DE3) containing pET25b as a negative control. In lane 4 is 
BL21 (DE3) containing pET16bFeoA as a positive control. 
Production of FeoC antibodies proceeded in a similar manner to that of FeoA. 
feoC was cloned into the expression vector pET25b which contains an N-terminal His-tag 
and the BL21 (DE3) cells were transformed with the pFeo128 plasmid. The cells were 
induced using IPTG and then passed over a nickel column to separate the His-tagged 
FeoC protein using an FPLC. Similar to FeoA, FeoC was in the insoluble fraction and a 
similar protocol was used to purify it.   
 
 
 
 
  
 
 
Figure 16. Coomassie-stained SDS-PAGE gel of FPLC purification of FeoC.  
Arrow indicates expected position of FeoC. In lane 1 is the molecular weight marker 
Presicion plus protein dual color standard (Bio-rad). The 10 kDa and 15 kDa positions 
are labeled. In lane 2 is DH5α containing the pFeo128 as a positive control. In lane 3 is 
1 Molecular Weight Marker 
2 pFeo128 whole cell 
3 BL21 (DE3) pET25b 
4 FPLC fraction C1 
5 FPLC fraction C2 
 
  1      2     3    4       5     
10 
15 
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BL21 (DE3) containing pET25b as a negative control. In lanes 4 and 5 are the FPLC 
fractions C1 and C2 containing purified FeoC.  
 
The fraction most likely to contain FeoC protein was analyzed using the Bradford 
assay and approximately 1 mg of protein was present (see Fig. 16 lanes 4 and 5).  Figure 
17 shows the pre-immune serum from the rabbits  that were used to generate FeoC 
antibodies. Lanes 2 and 3 are used as controls. pFeo128 is the plasmid used to express 
FeoC in BL21 (DE3) cells. pET25b was used to create pFeo128 and is the vector alone. 
The FPLC fractions containing FeoC was sent to Cocalico Biologicals, Inc. for antibody 
production in two rabbits. A total of 6 immunizations against FeoC were performed in 
each rabbit. The western blot in Figure 17 shows that rabbit serum (UT639 and UT640) 
showed a high level of reactivity to E. coli proteins, so it was likely that the rabbits had 
an E. coli infection prior to immunization.  
 
 
 
 
 
 
Figure 17. Pre-immune serum for FeoC activity.  
1: DH5α pET16b whole cell 
2: DH5α pFeo101 whole cell 
3: purified FeoC 
1      2    3 
UT639 UT640 
1      2    3 
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Arrow indicates expected position of FeoC. Serum from rabbits UT639 and UT640. 
Serum was diluted 1:200 in 5% powdered milk and TBS-Tween. In lane 1 is DH5α 
containing pET16b alone. In lane 2 is DH5α containing pFeo101. In lane 3 is purified 
FeoC from the FPLC fraction C1.  
 
As evidenced by the western blot in Figure 18, the antisera reacted similarly to 
cells expressing the Feo system and to cells that contained the expression vector only 
(Figure 18 Lanes 2 and 1 respectively). The bands in lanes 1 and 2 indicates that the 
rabbit is reacting with endogenous E. coli proteins found in the DH5α strain, and that 
they most likely encountered E. coli  previously as evidenced by the activity of the pre-
immune serum. However, the antibodies also react strongly with purified V. cholerae 
FeoC, indicating that antibodies do bind to V. cholerae FeoC strongly. Further 
purification will be needed to isolate the antibodies reacting to V. cholerae FeoC. 
 
 
 
 
 
 
 
 
Figure 18. Activity of antibody against FeoC.  
1: DH5α pET16b 
2: DH5α pFeo101  
3: purified FeoC 
1   2    3 1   2    3 
 UT639  UT640
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Arrow indicates expected position of FeoC. Serum from rabbits UT639 and UT640. 
Serum was diluted 1:1000 into 5% powdered milk and TBS-Tween. Lane 1 contains 
DH5α containing the pET16b vector as a negative control. In lane 2 is DH5α containing 
pFeo101 as a positive control. In lane 3 is purified FeoC from the FPLC fraction C1. 
 
Conclusions 
In light of the experiments performed in this work, it seems that certain amino 
acid residues are important for the interaction between FeoB and FeoC. A residue of 
FeoB reputed to be part of the switch region and responsible for nucleotide-dependent 
rearrangement in the G protein domain was not necessary for interaction between FeoB 
and FeoC as assayed in the BACTH system. However, a conserved residue of FeoC was 
important for this interaction. Further examination of the important residues in each 
protein may reveal the function of FeoC and whether it regulates the function of FeoB. 
The antibodies produced in the course of this study will expedite the study of the proteins 
in the Feo system. These antibodies can be used to probe protein-protein interactions in 
cross-linking studies, as well as other experiments to understand the Feo system. 
However, many questions remain about the Feo system. It remains to be determined 
whether FeoB functions as monomer, dimer, or trimer. The function of FeoA and FeoC 
still needs to be determined. It also needs to be determined whether FeoB is modulated by 
any other protein, such as FeoC.  
Further characterizing this system may allow understanding of the ferrous iron 
transport in V. cholerae as well as many other organisms. Feo is conserved across 
bacteria and archaea, and seems to be important for iron-acquisition while in the micro-
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aerophilic, reducing conditions of the human host. Understanding this system may lead to 
better treatment against pathogens such as V. cholerae. This study has helped identify 
amino acid residues that are important for interaction between proteins of the Feo system 
as well as provide tools for further study of this conserved system.  
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